Capital International Sarl Novo Cure LTD Transaction History

Capital International Sarl

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$40.29 - $82.51 $475,945 - $974,690	-11,813 Reduced 13.95%	72,886 $3.02 Million
Q1 2023 May 15, 2023	BUY	$56.44 - $118.81 $1.17 Million - $2.47 Million	20,758 Added 32.46%	84,699 $5.09 Million
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $582,729 - $777,549	9,108 Added 16.61%	63,941 $4.69 Million
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $405,832 - $534,643	-5,969 Reduced 9.82%	54,833 $4.17 Million
Q2 2022 Aug 15, 2022	BUY	$56.6 - $89.9 $521,908 - $828,967	9,221 Added 17.88%	60,802 $4.23 Million
Q1 2022 May 16, 2022	BUY	$60.15 - $84.52 $315,005 - $442,631	5,237 Added 11.3%	51,581 $4.27 Million
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $2.61 Million - $4.24 Million	34,792 Added 301.18%	46,344 $3.48 Million
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $176,926 - $296,299	-1,523 Reduced 11.65%	11,552 $1.34 Million
Q2 2021 Aug 16, 2021	BUY	$130.4 - $225.58 $310,091 - $536,429	2,378 Added 22.23%	13,075 $2.9 Million
Q1 2021 May 14, 2021	BUY	$124.11 - $190.17 $67,019 - $102,691	540 Added 5.32%	10,697 $1.41 Million
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $50,247 - $78,014	448 Added 4.61%	10,157 $1.76 Million
Q3 2020 Nov 16, 2020	BUY	$58.05 - $111.31 $121,963 - $233,862	2,101 Added 27.62%	9,709 $1.08 Million
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $41,012 - $53,351	717 Added 10.4%	7,608 $451,000
Q1 2020 May 15, 2020	SELL	$57.05 - $95.75 $51,858 - $87,036	-909 Reduced 11.65%	6,891 $464,000
Q4 2019 Feb 18, 2020	BUY	$68.3 - $93.8 $532,740 - $731,640	7,800 New	7,800 $657,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Capital International Sarl, based on Form 13F filings with the SEC.

Stay updated on Capital International Sarl with notifications on news.